SCHEDULE: Vanguard Discloses Agilent Technologies Stake

Vanguard Portfolio Management reports beneficial ownership of over 14.3 million shares, representing 5.09% of Agilent Technologies Inc.'s common stock as of March 31, 2026.

Summary

• Vanguard Portfolio Management, along with its affiliates Vanguard Fiduciary Trust Company and Vanguard Global Advisers, LLC, has filed a Schedule 13G indicating beneficial ownership of Agilent Technologies Inc. common stock.
• As of March 31, 2026, the total number of shares beneficially owned is 14,387,171.
• This holding represents 5.09% of the class of securities.
• Vanguard Portfolio Management has sole dispositive power over 14,387,171 shares and sole voting power over 34,489 shares.
• The filing clarifies that this Schedule 13G includes securities held by Vanguard funds and other managed accounts where Vanguard Portfolio Management exercises dispositive power.
• No single other person's interest in the reported securities exceeds 5%.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It's a standard regulatory disclosure of ownership by a large institutional investor and does not provide new performance data or strategic insights.

Positives

• Vanguard, a significant institutional investor, holds a substantial stake in Agilent Technologies, indicating confidence in the company's long-term prospects.
• The filing confirms that Vanguard manages these holdings in the ordinary course of business, not for the purpose of influencing control.

Future Outlook

The filing does not contain forward-looking statements or guidance. It is a disclosure of beneficial ownership.

Industry Context

StockSavvy.ai notes that a Schedule 13G filing by a major asset manager like Vanguard typically signifies a passive investment stake, often held within various investment funds. This level of ownership (5.09%) suggests Agilent Technologies is a significant holding within Vanguard's portfolio, reflecting its position in the life sciences and diagnostics industry.

Stakeholder Impact

• Shareholders: The filing confirms a significant passive investment by Vanguard, which can be viewed positively as it indicates sustained institutional interest in Agilent Technologies.
• Management: The filing does not directly impact management but reinforces the company's position as a significant player in its industry, attracting large institutional investors.

Key Dates

Keywords

Agilent Technologies, Vanguard Portfolio Management, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing